Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT00801320

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

NCT03030287

Conditions
Adnexal Diseases, Cancer Ovaries, Cancer Peritoneal, +17 more
Locations
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. (Moffitt Cancer Center) Tampa, Florida, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

NCT01139957

Conditions
Adnexal Diseases, Breast Carcinoma, Breast Diseases, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View all 141 locations
View Trial Details
Completed

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

NCT02121990

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer

NCT02092363

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OU Medical Center Laboratory Oklahoma City, Oklahoma, United States
  • The University of Pennsylvania Health System Philadelphia, Pennsylvania, United States
  • Fox-Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions